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In an attempt to find the risk of relapse and factors predictive of risk of relapse, 97 children with epilepsy, withdrawn from their
medication, followed in our outpatient clinic from 1990 to 1995 were included in this study. The overall relapse rate was 20.6%.
All relapses occurred within 2 years after withdrawal started. Female gender, age at onset of seizures of more than 2 years,
and the duration of withdrawal were found to be significant risk factors in relapse rate following univariate analysis. However,
gender was not found to be significant in multivariate analysis. All other factors, including the duration of seizures prior to
starting antiepileptic drug (AED) treatment, the number of seizure before the start of AED treatment, the period between AED
induction and control of seizures, diagnostic yield from electroencephalogy (EEG) at diagnosis, the number of seizures after
the onset of AED therapy, length of seizure-free period, aetiology of the seizures, a history of epilepsy in the immediate family,
or previously experienced febrile convulsions were not significant factors in relapse rate. Significant risk factors for relapse rate
also significantly affected relapse time. We conclude that when AED therapy is withdrawn from children with uncomplicated
epilepsy, as in our patients, the two important risk factors, age at onset of seizures and the duration of withdrawal, can predict a
poor prognosis with a higher relapse rate: this needs taking into consideration.
c© 1999 BEA Trading Ltd
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INTRODUCTION
Long-term adverse effects of antiepileptic
drugs (AEDs) are well known, particularly in chil-
dren1. When making a decision to discontinue AEDs
in epileptic children after a sufficient seizure-free pe-
riod, long-term side-effects of continued medication
as well as various factors associated with the risk of
relapse must be taken into consideration.
In recent years, several studies have been conducted
to determine the risk of relapse after AED withdrawal:
there is, however, no general agreement on criteria that
can predict safe discontinuation or subsequent recur-
rence of seizures, particularly in children with uncom-
plicated epileptic seizures2–6.
This study was designed to identify the risk factors
associated with relapse after AED withdrawal in chil-
dren with uncomplicated epileptic seizures.
MATERIALS AND METHODS
This study was carried out on patients with epilepsy
followed in our outpatient clinic in the Department
of Paediatric Neurology. One hundred and seventy-
nine patients who were first admitted to our clinic be-
tween 1991 and 1995 and whose anticonvulsant med-
ications had been stopped were considered for investi-
gation. All patients had at least two afrebrile seizures
before the age of 12, which were not due to metabolic
or infectious disease of the central nervous sys-
tem (CNS). Patients with neonatal convulsions, pro-
gressive CNS disorder, any inborn error of metabolism
or febrile convulsion were excluded: 97 patients were
not excluded from this study (58 boys, 39 girls). Age at
onset of first seizure varied from 2 months to 12 years
(mean± SD : 4.5 ± 3.3 years). Age during the study
period varied from 4 to 20 years (mean± SD : 12.5±
3.6 years). The patients who did not have a recur-
rence had been followed for at least 2 years (max.
48 months).
Seizures were classified according to the classifica-
tion of seizures of the International League Against
Epilepsy7. Of the 25 children (26% with general-
ized seizures) 6 had tonic, 15 had tonic–clonic, 2 had
absence, and 2 had myoclonic seizures. Ten chil-
dren (10.3%) had simple partial seizures, 43 chil-
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dren (44.3%) had complex partial seizures and 19 chil-
dren (19.5%) had secondary generalized seizures.
Seven out of 10 patients with simple partial seizures
were diagnosed as having benign childhood epilepsy
with centrotemporal spikes (benign rolandic epilepsy).
Of two absence seizures, one was typical of juve-
nile absence epilepsy and the other atypical with the
Lennox–Gastaut syndrome. Two children with my-
oclonic seizures had infantile spasms. Of the total
of 43 patients with complex partial seizures, 2 pa-
tients were diagnosed as having benign occipital lobe
epilepsy. Because of the relatively small number of pa-
tients in some seizure types and epileptic syndromes,
seizure types were merged into generalized and par-
tial seizures. Hence, 25 patients (26%) had generalized
seizures and 72 patients (74%) partial seizures.
The patients were divided into various groups based
on the risk factors for relapse (Table 1). All but three
patients had one or more interictal electroencepha-
logy (EEG) recordings performed at diagnosis. In
these three patients and in patients with a normal
EEG, diagnosis and determination of seizure type
were made clinically. An EEG recorded within a year
before withdrawal was accepted as the withdrawal
EEG. Since 93 of the patients (96%) had a normal
withdrawal EEG and the other four patients had an
EEG with only paroxysmal slow waves, withdrawal
EEGs were excluded from the analysis. A withdrawal
period of less than 1 month was categorized as a sud-
den discontinuation, and was excluded from analysis.
Fifty-seven patients (58%) were on phenobarbitone,
19 (20%) on carbamazepine, 10 (10%) on valproic
acid, 9 (10%) on diphenylhydantoin, and 2 (2%) on
more than one AED.
Patients were aetiologically classified according to
the method described by Hauser and Kurland8. If the
patients had a static encephalopathy from birth or ac-
quired prior to the first seizure or had any prior neu-
rological insult such as stroke or head trauma (associ-
ated with a depressed skull fracture, loss of conscious-
ness for longer than 30 minutes or intracranial bleed-
ing), they were classified as ‘remote symptomatic’.
In addition, those with mental retardation were esti-
mated clinically, not by formal psychological testing
results. According to this clinical estimation some pa-
tients were accepted that had a mild mental retarda-
tion. None of the patients had moderate to severe men-
tal retardation. If a patient had a history of stage II
and III hypoxic-ischaemic encephalopathy at birth, the
patient was included in the remote symptomatic group.
All the other patients with unprovoked seizures were
classified as idiopathic.
Initially, clinically a 4-year seizure-free period plus
an EEG without active epileptic discharges within a
year before withdrawal was used as the criteria for
AED discontinuation. Later, 2–3 years of seizure free-
dom and a normal EEG were taken as criteria for with-
drawal, relying on recent literature9–11. Family history
was considered ‘positive’ if there was a history of one
or more unprovoked seizures in the immediate family
(parents or sibling).
The factors used in evaluation included gender, age
at onset, duration of seizures prior to starting the AED,
number of seizures prior to starting the AED, duration
between the onset of seizures and starting the AED,
number of seizures after starting the AED, length of
the seizure-free period, duration of withdrawal (taper-
ing period), aetiology, nature of EEG support for the
diagnosis, family history of epilepsy and a history of
previous febrile convulsions.
The BMDP and SPSSx Statistical Packages were
used in the analysis. The chi-squared test or Fisher’s
exact test was used in assessing the univariate asso-
ciations between categorical responses. Factors that
might simultaneously have important effects on re-
lapse rate and relapse time were determined by the
methods of multivariate logistic regression and Cox
proportional hazard models, respectively12, 13.
RESULTS
Seizures after withdrawal occurred in 20 chil-
dren (20.6%) (Fig. 1) of whom 6 (30%) had a re-
lapse within the first 3 months, 9 (45%) within the
first 6 months, 14 (70%) within the first 12 months,
all within the first 2 years after the start of withdrawal.
The relapse rate for patients whose first seizure
occurred before the age of 2 was 5.3%, whereas it
was 30.5% for children whose seizures began after the
age of 2. This difference was statistically significant


















Fig. 1: Remission rates of all patients after withdrawal.
386 S¸. Altunbas¸ak et al.




<24 months 38 39 5.3
>24 months 59 61 30.5a
Gender
Boy 58 60 13.8
Girl 39 40 30.8a
The period between the onset of seizures and the onset of AED therapy
0–3 months 59 61 20.3
4–6 months 14 14 28.6
7–12 months 8 8 18.8
>12 months 16 17 21.4
The number of seizures before AED therapy
<10 seizures 73 75 20.5
>10 seizures 24 25 20.8
The period between the onset of AED therapy and control of seizures
0–3 months 60 62 23.7
4–6 months 16 6 0
7–12 months 8 7 14.3
>12 months 24 25 20
The number of seizures after starting AED therapy
<10 seizures 81 83 23.1
>10 seizures 16 17 6.3
The period between seizure control and starting withdrawal (seizure-free period)
<2 years 10 10 40
2–3 years 25 26 20
>3 years 62 64 17.7
EEG at diagnosis
No EEG 3 3 —
Normal EEG 11 11 36
EEG with paroxysmal slow waves 52 54 11.8
EEG with sharp waves, spike-and waves, polyspike-and waves 31 32 28.1
The duration of withdrawal (tapering period)
1–5 months 18 19 38.9a
>5 months 79 81 16.5
Aetiology
Idiopathic 72 74 21.4
Remote symptomatic 25 26 15.4
Family history of epilepsy
Positive 10 11 20.7
Negative 87 89 20
History of previous febrile convulsion
Positive 38 39 21.1
Negative 59 61 20.3
a P < 0.05
The relapse rates according to gender were 13.8%
for boys, 30.8% for girls and the difference was sta-
tistically significant in univariate analysis (P < 0.05)
(Fig. 3).
The relapse rate for the patients whose medica-
tion was withdrawn gradually over 2–5 months was
38.9%, whereas it was 16.5% for the patients whose
drug was withdrawn over more than 5 months. The
difference was statistically significant (P < 0.05)
(Fig. 4). No other factors were statistically signifi-
cant.
Since some groups of seizure types included a small
number of patients, we could not evaluate the differ-
ence between these groups in terms of relapse rate,
but could evaluate the difference between the relapse
rates for patients with generalized and partial seizures:
it was not significant (P > 0.05), (Table 1). All
seven patients with benign rolandic epilepsy did not
relapse. One of two children with benign occipital lobe
epilepsy relapsed but the other did not. The children
with infantile spasm (n = 2), Lennox–Gastaut syn-
drome (n = 1) and juvenile absence epilepsy (n = 1)
did not have a recurrence. Because these epileptic syn-
dromes include a very small number of patients, we
were unable to evaluate them in terms of relapse rate.
Multivariate Analysis
In order to investigate the influence of several factors
simultaneously on the relapse rate, multivariate logis-
tic regression was applied. An age of onset of more

















ASO = Age of seizure onset
A = ASO < 24 months















































A = Duration of discontinuation < 5 months
B = Duration of discontinuation > 5 months
30 40 50
Fig. 4: The relationship between remission rate and duration
of discontinuation.
Table 2: Shows significant risk factors for relapse rate
following withdrawal of AED therapy in children: multivariate
analysis using a logistic regression model.
Risk Factors Relative Risk 95% Confidence P
interval
Withdrawal time 0.218 0.0496–0.957 0.04a
Age of seizure onset 7.41 1.30–42.2 0.008a
a P < 0.05
than 2 years, and duration of AED withdrawal less
than 6 months were found to be significant risk factors
in predicting a poor outcome. Gender was found not
to be a significant risk factor by multivariate analysis
(Table 2).
The risk factors affecting relapse rate (age at onset
and the length of withdrawal) were also found to sig-
nificantly affect relapse time (P < 0.05) (Table 3).
Table 3: Shows significant risk factors for relapse time
following withdrawal of AED therapy in children: multivariate
analysis using Cox Proportional Hazards Model.
Risk Factors Relative Risk 95% Confidence P
interval
Withdrawal time 0.270 0.077–0.929 0.037a
Age of seizure onset 6.82 1.41–33 0.04a
a P < 0.05
DISCUSSION
The overall relapse rate was 20.6% in our study. Re-
ported rates have varied from 22.4% to 40% in other
studies3, 5, 9, 14, 15. This discrepancy may be due to the
heterogeneity of the population, follow-up periods and
statistical methods used. Our relatively lower relapse
rate can be explained by most of the EEGs being nor-
mal before withdrawal, by not including patients with
neurological deficits or with moderate to severe mental
retardation and not including types of epilepsy known
to have a poor prognosis on drug withdrawal such
as juvenile myoclonic or severe infantile myoclonic
epilepsy.
All recurrences occurred within the first 2 years.
In other studies, 85–90% of recurrences were re-
ported within 2 years3, 5, 16, suggesting all patients be-
ing withdrawn should be followed clinically and elec-
trographically for at least the first 2 years after drug
withdrawal. We found that being female was a signifi-
cant risk factor with a 30.8% relapse rate on univariate
analysis. This finding is in agreement with some stud-
ies17, 18, although most other studies have reported the
opposite3, 10, 13, 14. Eighty-four percent of our female
patients at the onset of seizures were more than 2 years
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old. This may explain the reason that the female gen-
der is found to be a significant risk factor in our study.
In Dooley et al. ’s study,17 the female gender was re-
ported to be a significant risk factor in both univariate
and multivariate analysis. This discrepancy may be ex-
plained by differences in study populations and some
features such as age at seizure onset, the state of the
EEG at the time of withdrawal and seizure type.
Some authors have, like us, also reported age at on-
set as a significant risk factor for recurrence3, 5, 11, 12.
But there are others who did not2, 14, 19. A young age
at onset was reported as a poor prognostic factor in
some studies3, 4, 20, but as a good prognostic factor in
others as in our study15, 16, 21: differences in the popu-
lations studied appears to explain this discrepancy. In
addition, some factors found to be significant by uni-
variate analysis may be found not to be significant by
multivariate analysis as in Emerson’s3 and our study.
We found age at onset of less than 2 years to be a
good prognostic factor. However, our population did
not include some types of epilepsy with a poor prog-
nosis, such as infantile spasms or the severe myoclonic
epilepsies of infancy.
We did not find any significant difference between
generalized or partial onset seizures. Some previous
studies2, 19, 22 have reported that seizure type is a sig-
nificant risk factor, whereas others3, 5, 9, 14 did not.
Our own studies and these latter studies did not sep-
arate out patients with benign epileptic syndromes.
For example, seven of our patients with simple par-
tial seizures had benign rolandic epilepsy: they had no
recurrence.
Seizure frequency, the time elapsed before the on-
set of AED treatment, the total number of seizures
and the time elapsed between starting AED treatment
and control of seizures were all considered as mea-
sures of epilepsy severity. None of these factors were
found to be a significant risk factor for relapse. In one
study10, seizure frequency and the time elapsed before
starting AED treatment; in two studies2, 14, the time
elapsed between starting AED treatment and seizure
control, in two studies3, 19, the number of seizures be-
fore seizure control, were reported to be significant
risk factors. There seems to be no concensus as to the
significance of the above factors on the risk of relapse.
A degree of mental retardation (moderate to severe)
and/or any neurological deficit, may have an effect on
relapse rate as shown in some studies4, 10, 14, 17, but
not in this study or others2, 3, 16. However, our remote
symptomatic group only included patients with mild
degrees of mental retardation.
One of the factors about which there is most dis-
agreement is seizure-free period. We did not find
any significant difference in relapse rate for differ-
ent seizure-free periods in agreement with some stud-
ies2, 4, 10, but not another11. Our study suggests that 2
years seizure free may be sufficient as a treatment pe-
riod. Certainly this conclusion is valid for populations
including patients with a normal EEG at the time of
withdrawal, without moderate to severe mental retar-
dation with no neurological abnormality, and without
an epilepsy syndrome with a poor prognosis. We could
not evaluate seizure-free periods of less than 2 years
because of an insufficient number of patients. Peters
et al. 23 reported no significant difference with re-
spect to a relapse rate of between 6 and 12 months of
seizure freedom in uncomplicated epileptic children.
Thus, because they did not compare other seizure-free
periods (18, 24, 36 months) they could not be cer-
tain that 6 months of seizure freedom was sufficient
for starting drug withdrawal. Two studies about with-
drawal were recently reported by Gunnar et al. and
Dooley et al. 17, 24 in which a seizure-free period of
just 1 year was found to be a sufficient treatment pe-
riod for epilepsy with simple partial seizures and with
benign centrotemporal spikes in a population of un-
complicated patients.
A history of epilepsy in the immediate family or
antecedent febrile convulsions were not reported as
significant risk factors in some studies4, 10 (as in this
study), but in other studies these were reported to be
significant risk factors5, 14.
EEG features at diagnosis do not predict the prog-
nosis for relapse as both ourselves and others have
reported20, 26, 27. Ninety-six percent of our patients at
withdrawal had a normal EEG. In the remainder, there
were minor abnormalities (such as episodic slow wave
activity). On our multivariate analysis, age at onset
and the length of withdrawal, but not female gender,
were also found to be significant risk factors. As ex-
plained above, 87% of our female patients were more
than 2 years of age at the onset of seizure, suggesting
that relapse was affected by age at onset not by female
gender. Emerson et al. 3 also reported factors of men-
tal retardation, age at onset, frequency of seizures and
EEG pattern to be significant for relapse rate in uni-
variate analysis, but only EEG pattern at withdrawal
and frequency of seizures were significant in multi-
variate analysis.
The two risk factors which were found to signifi-
cantly affect relapse rate, age at onset and the dura-
tion of withdrawal also had an effect on relapse time.
The relapse time for patients with these two factors
was shorter than that of others. Most studies have also
reported that risk factors that affect relapse rate also
affect relapse time3, 15, 16.
In conclusion, the overall relapse rate was 20.6%
among young patients with epilepsy whose medica-
tion was withdrawn. All the relapses occurred within
2 years. When contemplating AED withdrawal in pa-
tients with uncomplicated epilepsy (as in our patients),
it should be remembered that 2 important risk factors,
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age at onset of seizure of more than two years and a
duration of withdrawal of less than 6 months, predict
a poor prognosis with a higher relapse rate.
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